Changes to an Approved Application for Specified Biotechnology and Specified Synthetic Biological Products
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
July 1, 1997
April 30, 2020
cb3f7a7e-cd25-442c-b55c-ea551ae637f8
Related Documents
Providing Regulatory Submissions to the Center for Biologics Evaluation and Research (CBER) in Electronic Format - Biologics Marketing Applications: Guidance for Industry
Guidance DocumentNovember 1, 1999Center for Biologics Evaluation and Research
Efficacy Studies to Support Marketing of Fibrin Sealant Products Manufactured for Commercial Use: Guidance for Industry
Guidance DocumentMay 20, 1999Center for Biologics Evaluation and Research
Recommendations for Collecting Red Blood Cells by Automated Apheresis Methods - Technical Correction February 2001: Guidance for Industry
Guidance DocumentFebruary 13, 2001Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox